newsfilter
← Latest News
GlobeNewswire·

Titan Pharmaceuticals, Inc. Announces Closing of Merger with Black Titan Corporation

  • Titan Pharmaceuticals, Inc. announced the successful closing of its merger with Black Titan Corporation & TalenTec Sdn. Bhd.
  • Titan became a wholly owned subsidiary of Black Titan Corporation effective October 1, 2025.
  • Each Titan common share was converted into one ordinary share of Black Titan on a one-for-one basis.
  • Titan ceased trading on the Nasdaq Capital Market at the close of business on October 1, 2025.
  • Black Titan's ordinary shares began trading on Nasdaq under the ticker symbol NASDAQ: BTTC on October 2, 2025.
  • ARC Group Ltd. served as the exclusive financial advisor for Black Titan Corporation during the transaction.
  • Chay W. J., CEO of Black Titan, stated the merger marks a new chapter for innovation & global expansion.